The abstract is read at the publisher; the summary is JClub's.
Epigenetic regulation links genetic susceptibility and environmental exposure in inflammatory bowel disease, enabling reproducible methylation signatures across immune and epithelial compartments.
- Why it matters: Genome-wide association and genetic risk scores explain only part of disease liability and have limited value for predicting course or treatment response, leaving residual risk from time-varying exposures insufficiently integrated.
- What they did: This Review synthesizes blood- and tissue-based methylation evidence to define regulatory signatures, and discusses how exposome influences, causal inference, multi-omics integration, and single-cell technologies improve interpretation and stratification.
- The result: Epigenetics is positioned as a framework for understanding inflammatory bowel disease heterogeneity and for informing clinical translation toward diagnosis, prognosis, and prediction of treatment response.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.